Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.270
-0.050 (-3.79%)
Oct 28, 2025, 4:00 PM EDT - Market closed
Standard BioTools Employees
As of December 31, 2024, Standard BioTools had 818 total employees, including 814 full-time and 4 part-time employees. The number of employees increased by 279 or 51.76% compared to the previous year.
Employees
818
Change (1Y)
279
Growth (1Y)
51.76%
Revenue / Employee
$210,600
Profits / Employee
-$147,313
Market Cap
485.13M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 818 | 279 | 51.76% |
| Dec 31, 2023 | 539 | 16 | 3.06% |
| Dec 31, 2022 | 523 | -92 | -14.96% |
| Dec 31, 2021 | 615 | -12 | -1.91% |
| Dec 31, 2020 | 627 | 61 | 10.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LAB News
- 8 days ago - Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025 - GlobeNewsWire
- 7 weeks ago - Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development - PRNewsWire
- 2 months ago - Standard BioTools Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study - GlobeNewsWire
- 3 months ago - Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025 - GlobeNewsWire
- 4 months ago - Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy - PRNewsWire
- 4 months ago - Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina - GlobeNewsWire
- 5 months ago - Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series - GlobeNewsWire